|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0025149,
umls-concept:C0025677,
umls-concept:C0205221,
umls-concept:C0205263,
umls-concept:C0728836,
umls-concept:C0871261,
umls-concept:C1518321,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2004-12-21
|
|
pubmed:abstractText |
To evaluate the feasibility of and response rate to an intensified induction chemotherapy regimen for young children with newly diagnosed high-risk or disseminated medulloblastomas.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4881-7
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15611503-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15611503-Cerebellar Neoplasms,
pubmed-meshheading:15611503-Child,
pubmed-meshheading:15611503-Child, Preschool,
pubmed-meshheading:15611503-Cisplatin,
pubmed-meshheading:15611503-Cyclophosphamide,
pubmed-meshheading:15611503-Disease Progression,
pubmed-meshheading:15611503-Disease-Free Survival,
pubmed-meshheading:15611503-Dose-Response Relationship, Drug,
pubmed-meshheading:15611503-Etoposide,
pubmed-meshheading:15611503-Female,
pubmed-meshheading:15611503-Humans,
pubmed-meshheading:15611503-Leucovorin,
pubmed-meshheading:15611503-Male,
pubmed-meshheading:15611503-Medulloblastoma,
pubmed-meshheading:15611503-Mesna,
pubmed-meshheading:15611503-Methotrexate,
pubmed-meshheading:15611503-Risk Factors,
pubmed-meshheading:15611503-Stem Cell Transplantation,
pubmed-meshheading:15611503-Transplantation, Autologous,
pubmed-meshheading:15611503-Treatment Outcome,
pubmed-meshheading:15611503-Vincristine
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
|
|
pubmed:affiliation |
Division of Pediatric Oncology, New York University Medical Center, New York, NY, USA. susan_chi@dfci.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
